Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 895-900

  Yashiro, Masakazu ^a   Chung, Yong Suk ^a   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Down regulation; Fibroblasts; Growth interaction; Scirrhous gastric cancer; Tranilast

Indexed keywords

TRANILAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FIBROBLAST; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER;

ADENOCARCINOMA, SCIRRHOUS; ANIMALS; ANTHRANILIC ACIDS; CELL DIVISION; DOWN-REGULATION; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030974568     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Elliott TE, Moertel CG, Wieand HS, Hahn RG, Gerstner JB, Tschetter LK and Mailliard JA: A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer. Cancer 65: 1491-1494, 1990.
2. Cullinan SA, Moetel CG, Wieand HS, O'Connell MJ, Poon MA, Krook JE, Malliard JA and Tschetter KL: Controlled evaluation of three drug combination regimens versus tluorouracil alone for the therapy of advanced gastric cancer. J Clin Oncology 12: 412-416, 1994.
3. Kurihara M, Izumi T, Yoshida S, Ohkubo T, Suga S, Kiyohashi A, Yaosaka T, Takahashi H, Ito T, Sasai T, Akiya T, Akazawa S, Betsuyaku T and Taguchi S: A cooperative randomized study on tegafur plus mytomycin C versus combined tegafur and uracil plus mytomycin C in the treatment of advanced gastric cxancer. Jpn J Cancer Res 82: 613-620, 1991.
4. Tahara, E: Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116: 121-131, 1990.
5. Maehara Y, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, Korenaga D and Sugimachi K: Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection. Surg Gynecol Obstet 175: 13-16, 1992.
6. Furukawa H, Hiratsuka M and Iwanaga T: A rational technique for surgical operation on Borrmann type 4 gastric carcinoma. Br J Surg 75: 116-119, 1988.
7. Sugano H, Nakamura K and Kato Y: Pathological studies of human gastric cancer. Acta Pathol Jpn Suppl 232: 329-347, 1982.
8. Yashiro M, Chung'y S and Sowa M:-Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 84: 883-886, 1994.
9. Suzawa H, Kikuchi S, Ami N and Koda A: The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keroid fibroblasts. Jpn J Pharmacol 60: 91-96, 1992.
10. Murray JC, Pollack SV and Pinnell SR; Keloids: a review. J Am Acard Dermatol 4: 461-470, 1981.
11. Azuma H, Banno K and Yoshimura T: Pharmacological properties of N-(3′.4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new antiatopic agent. Br J Pharmacol 58: 483-488, 1976.
12. Yashiro M, Chung YS, Nishimura S, Inouc T and Sowa M: Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer 72: 1200-1210, 1995.
13. Sun J, Qian Y, Hamilton AD and Sebti SM: Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-ras mutation and p53 deletion. Cancer Res 55: 4243-4247, 1995.
14. Chiquet-Ehrismann R, Kalla P and Pearson AC: Participation of tenascin and transforming growth factor-β in reciprocal epithelialmesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res 49: 4322-4325, 1989.
15. Cronil I, Theodorescu D, Man S, Herlyn M, Jabrosic J and Kerbel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88: 6028-6032, 1991.
16. Ankrapp PD and Bevan RD: Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro. Cancer Res 55: 3399-3404, 1993.
17. Cleave M, Hsich TJ, Gao C, Eschenbach CA and Chung LWK: Acceleration of human prostate cancer growth in vitro by factors produced by prostate and bone fibroblasts. Cancer Res 57: 3753-3761, 1989.
18. Yashiro M, Chung YS, Kubo T, Hato F and Sowa M: Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer 74: 1094-1103, 1996.
19. Goto Y, Tsuchiya O, Nishiyama M, Suzawa H and Miyata H: Studies on the metabolic fate of tranilast in rats and mice: pharmacokinctic studies in plasma, skin and granulation tissue. Clin Report 25: 4767-4772, 1991.
20. Suzawa H, Kikuchi S, Ichikawa K and Koda A: Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 60: 85-90, 1992.
21. Yamada H, Tajima S, Nishikawa T, Mur ad S and Pinnel SR: Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem 770: 892-897, 1994.
22. Wu X, Fan Z, Masui H, Rosen N and Mendelsohn J: Apoptosis induced by anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95: 1897-1905, 1995.
23. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstur J, Rabin R, Zoltick P and Baserga R: The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55: 2463-2469, 1995.
24. Zhang X, Giangreco L, Broome HE, Dargan CM and Swain SL: Control of CD4 effecter fate: transforming growth factor beta 1 and interleukin 2 synergizc to prevent apoptosis and promote effecter expansion. J Exp Med 752: 699-709, 1995.
25. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jakobson MD: Programmed cell death and the control of cell survival: lessons from the nevous system. Science 262: 695-700, 1993.
26. Reed JC: Bcl-2 and regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
27. Yonisch-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukemyc cells that is inhibited by interleukin-6. Nature 552: 345-347, 1991.
28. Saiki I, Murata J, Yoneda J, Kobayashi H and Azuma I: Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J Cancer 56: 867-873, 1994.
29. Gohji K, Nakajima M, Fabra A, Bucana DC, Eschenbach CA, Tsuruo T and Fidler U: Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn J Cancer Res 55: 152-160, 1994.